Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.50 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.50 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | CNR1 | P21554 | 1/20 | 0.47 |
| ▸ | CNR2 | P34972 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.44 |
| ▸ | CDC25A | P30304 | 1/20 | 0.44 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.44 |
| ▸ | AKT1 | P31749 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2561609 | 1.00 | ALDH1A1 (0.66) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL4619498 | 0.99 | ALDH1A1 (0.64) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL4619726 | 0.99 | ALDH1A1 (0.64) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL479563 | 0.99 | ALDH1A1 (0.64) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL479610 | 0.99 | ALDH1A1 (0.64) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL37559 | 0.96 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL479222 | 0.96 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL671456 | 0.96 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL672371 | 0.96 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL479388 | 0.96 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4695401-A1 | SYNTHETIC CIRCUITS AND USES THEREOF | Strand Therapeutics Inc. (US) | 2026-02-18 | — | — | EP | claimed |
| WO-2024216162-A1 | SYNTHETIC CIRCUITS AND USES THEREOF | STRAND THERAPEUTICS INC. (US) | 2024-10-17 | — | — | WO | claimed |
| WO-2013152325-A1 | PLASMINOGEN-OXIDIZED PHOSPHOLIPIDS FOR THE DETECTION OF CARDIOVASCULAR DISEASES AND DISORDERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-10-10 | — | — | WO | claimed |
| EP-1562624-A4 | ORALLY ADMINISTERED PEPTIDES SYNERGIZE STATIN ACTIVITY | UNIV CALIFORNIA (US) | 2009-07-29 | — | — | EP | claimed |
| EP-1789035-A2 | ORALLY ADMINISTERED SMALL PEPTIDES SYNERGIZE STATIN ACTIVITY | The Regents of the University of California-San Francisco (US) | 2007-05-30 | — | — | EP | claimed |
| JP-2007512228-A | — | — | 2007-05-17 | — | — | JP | claimed |
| EP-1496930-A4 | G-TYPE PEPTIDES TO AMELIORATE ATHEROSCLEROSIS | UNIV CALIFORNIA (US) | 2006-06-21 | — | — | EP | claimed |
| EP-1660112-A2 | ORALLY ADMINISTERED SMALL PEPTIDES SYNERGIZE STATIN ACTIVITY | The Regents of the University of California (US) | 2006-05-31 | — | — | EP | claimed |
| WO-2006020652-A2 | ORALLY ADMINISTERED SMALL PEPTIDES SYNERGIZE STATIN ACTIVITY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-02-23 | — | — | WO | claimed |
| EP-1562624-A2 | ORALLY ADMINISTERED PEPTIDES SYNERGIZE STATIN ACTIVITY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-08-17 | — | — | EP | claimed |
| EP-1496930-A2 | G-TYPE PEPTIDES TO AMELIORATE ATHEROSCLEROSIS | The Regents of The University of California (US) | 2005-01-19 | — | — | EP | claimed |
| EP-1272666-A4 | A FUNCTIONAL ASSAY OF HIGH-DENSITY LIPOPROTEIN | UNIV CALIFORNIA (US) | 2004-09-22 | — | — | EP | claimed |
| WO-2004034977-A2 | ORALLY ADMINISTERED PEPTIDES SYNERGIZE STATIN ACTIVITY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2004-04-29 | — | — | WO | claimed |
| WO-2003086326-A2 | G-TYPE PEPTIDES TO AMELIORATE ATHEROSCLEROSIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2003-10-23 | — | — | WO | claimed |
| EP-1318828-A1 | ORALLY ADMINISTERED PEPTIDES TO AMELIORATE ATHEROSCLEROSIS | The Regents of the University of California (US) | 2003-06-18 | — | — | EP | claimed |
| EP-1274862-A1 | CONTROL OF A GENE INDUCED BY OXIDIZED LIPIDS IN HUMAN ARTERY WALL CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2003-01-15 | — | — | EP | claimed |
| EP-1272666-A1 | A FUNCTIONAL ASSAY OF HIGH-DENSITY LIPOPROTEIN | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2003-01-08 | — | — | EP | claimed |
| WO-2002015923-A1 | ORALLY ADMINISTERED PEPTIDES TO AMELIORATE ATHEROSCLEROSIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2002-02-28 | — | — | WO | claimed |
| WO-2001075170-A1 | A FUNCTIONAL ASSAY OF HIGH-DENSITY LIPOPROTEIN | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2001-10-11 | — | — | WO | claimed |
| WO-2001075168-A1 | CONTROL OF A GENE INDUCED BY OXIDIZED LIPIDS IN HUMAN ARTERY WALL CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2001-10-11 | — | — | WO | claimed |